New York State Common Retirement Fund

New York State Common Retirement Fund’s Opus Genetics IRD Stock Holding History

New York State Common Retirement Fund’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.6K	Buy	+14,500	New	+$67.6K	﹤0.01%	2925

Other funds holding IRD

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

First City Capital Management Savannah, Georgia $206M AUM 26.13% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

GGM Financials Columbus, Ohio $264M AUM 15.28% 1-Year Est. Return

New York State Common Retirement Fund's IRD Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Opus Genetics (IRD) in Q2 2026: 14,500 shares worth $59.6K. The stake represents ﹤0.01% of the portfolio and ranks #2925 among its holdings.

14 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

New York State Common Retirement Fund held 14,500 shares of Opus Genetics worth $59.6K as of Q2 2026.
Opus Genetics was a new New York State Common Retirement Fund position in Q2 2026.
Opus Genetics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2925 holding.
14 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.